Literature DB >> 6170423

Amylase-producing lung cancer: case report and review of the literature.

S Katayama, M Ikeuchi, Y Kanazawa, Y Akanuma, K Kosaka, T Takeuchi, T Nakayama.   

Abstract

A case of hyperamylasemia with lung cancer is described. Macroamylasemia was excluded by a normal amylase/creatinine clearance ratio and by a sedimentation constant obtained by sucrose density gradient centrifugation. Positive immunofluorescent staining of tumor cells with a specific antibody against human salivary amylase and significant amylase activity in the primary tumor and metastases support the hypothesis of independent production of amylase by the lung tumor. Cellulose--acetate membrane electrophoresis demonstrated three bands of amylase activity. The major component corresponded to normal salivary amylase in electrophoretic mobility, isoelectric point and molecular size. The minor bands, one of which occupied about 10% of the total amylase activity in serum, urine and tissue homogenates, demonstrated a lower electrophoretic mobility and a more acidic isoelectric point. Gel filtration and electrophoresis disclosed that these minor bands were derived from an amylase isozyme with a larger molecular size than that of normal salivary amylase. The results suggest ectopic tumor production of heterogenous amylase isozymes, with the larger form being secreted into the circulation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170423     DOI: 10.1002/1097-0142(19811201)48:11<2499::aid-cncr2820481125>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Ultrastructural, immunohistochemical and biochemical studies on amylase and ACTH producing lung cancer.

Authors:  Y Yoshida; M Mori; T Sonoda; F Sakauchi; H Sugawara; A Suzuki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

2.  Amylase mRNA transcripts in normal tissues and neoplasms: the implication of different expressions of amylase isogenes.

Authors:  K Seyama; T Nukiwa; K Takahashi; H Takahashi; S Kira
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.